Jonathan Kaufman

Associate
jkkaufman@cooley.com
Full contact info

Jonathan focuses his practice on commercial and intellectual property transactions for Cooley’s public and private clients in the life sciences industry.

About Jonathan

Jonathan focuses his practice on commercial and intellectual property transactions for Cooley’s public and private clients in the life sciences industry. Jonathan has helped to structure and negotiate a variety of collaboration and license agreements, with the goal of maximizing the value of a company’s products and technology assets. 

View full bio

Passions

Constructing and solving crossword puzzles

Visiting baseball stadiums

Spending time with his dog, Conan

Experience

Radionetics Oncology Announces Strategic Agreement With Eli Lilly

Radionetics Oncology Announces Strategic Agreement With Eli Lilly

July 1, 2024

Cooley advised Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein-coupled receptor (GPCR)-targeted radiopharmaceuticals to treat a broad range of solid tumors, on the formation of a strategic agreement with Eli Lilly to take forward Radionetics’ proprietary GPCR-targeting small molecule radiopharmaceuticals. Under the terms of the agreement, Radionetics received a $140 million up-front cash payment. Additionally, Lilly obtained the exclusive right to acquire Radionetics for $1 billion upon conclusion of an exercise period.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Charity Williams
Partner, San Diego
Jenny Ge
Associate, Los Angeles Santa Monica
Chen Chen
Associate, Palo Alto
Todd Gluth
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Howard Morse
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Ajay Athavale
Associate, San Francisco
Kyle Hess
Associate, New York
Jonathan Kaufman
Associate, Palo Alto
Allison Kutner
Associate, New York
Edmond Lay
Associate, San Diego
Jeremy Gentile
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Breanna Qin
Associate, Palo Alto
Megan Drill
Associate, San Diego
Daniel Gillon
Associate, San Diego
Jack Whitaker
Associate, San Diego
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Life Sciences
Mergers and Acquisitions
Life Sciences Corporate Partnering and Licensing
Tax
Life Sciences and Healthcare Regulatory
Compensation and Benefits
Cyber/Data/Privacy
Antitrust and Competition
Labor and Employment
CFIUS

SystImmune Announces Global Strategic Collaboration With Bristol Myers Squibb

SystImmune Announces Global Strategic Collaboration With Bristol Myers Squibb

December 11, 2023

Cooley advised SystImmune, a clinical-stage biopharmaceutical company, on its exclusive license and collaboration agreement with Bristol Myers Squibb for SystImmune’s BL-B01D1.

Read more

Related contacts

Kate Hillier
Partner, Seattle
Lila Hope
Partner, Palo Alto
Chen Chen
Partner, Boston
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Rick Jantz
Associate, Los Angeles Santa Monica
Jonathan Kaufman
Associate, Palo Alto
Zack Gong
Associate, Shanghai
Rena Kaminsky
Special Counsel, Palo Alto
Freddy Yip
Associate, Hong Kong
David D. Suh
Associate
David Burns
Special Counsel, Washington, DC
Rubin Waranch
Associate, Colorado
Andrew Epstein
Special Counsel, Seattle
Daniel Millard
Associate, London
Zhijing Yu
Associate, Singapore
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Christopher Kimball
Partner, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC

Related Practices & Industries

Life Sciences
Life Sciences Corporate Partnering and Licensing
Tax
Antitrust and Competition
Cyber/Data/Privacy
Arbitration
Life Sciences and Healthcare Regulatory
CFIUS

SCYNEXIS Announces Exclusive License Agreement With GSK for Brexafemme

SCYNEXIS Announces Exclusive License Agreement With GSK for Brexafemme

April 4, 2023

Cooley advised SCYNEXIS on its exclusive license agreement with GSK for Brexafemme.

Related contacts

Marya Postner
Partner, Palo Alto
Carly Robinson
Associate, Reston
Bin Wang
Special Counsel, Palo Alto
Jonathan Kaufman
Associate, Palo Alto
Barbara Borden
Partner, San Diego
Rebecca Givner-Forbes
Special Counsel , Washington, DC
Matthew Hemington
Partner, Palo Alto
David Burns
Special Counsel, Washington, DC
Nicollette R. Kirby
Associate, Washington, DC
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Michael Egan
Partner, Washington, DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Natasha Leskovsek
Of Counsel, Washington, DC

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Life Sciences
Healthcare
Medtech
Emerging Companies
Capital Markets
Venture Capital
Mergers and Acquisitions
Tax
Cyber/Data/Privacy
Antitrust and Competition
Trademark, Copyright and Advertising

Admissions and credentials

California